1. BENDAMUSTINE AS PART OF CONDITIONING REGIMEN FOR AUTOLOGOUS STEM‐CELL TRANSPLANTATION IN PATIENTS WITH AGGRESSIVE LYMPHOMAS: FINAL ANALYSIS OF A PHASE 2 STUDY FROM GELTAMO. (June 2017) Authors: Martín, A.; Redondo, A.M.; Valcárcel, D.; González, A.P.; Suárez‐Lledó, M.; Bello, J.L.; Canales, M.; Gayoso, J.; Conde, E.; Jarque, I.; del Campo, R.; Arranz, R.; Terol, M.J.; Rifón, J.; Rodríguez, M.J.; Ramírez, M.J.; Castro, N.; Sánchez, A.; López‐Jiménez, J.; Briones, J. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. TIPIFARNIB IN RELAPSED OR REFRACTORY ANGIOIMMUNOBLASTIC T‐CELL LYMPHOMA (AITL) AND CXCL12+ PERIPHERAL T‐CELL LYMPHOMA (PTCL): PRELIMINARY RESULTS FROM A PHASE 2 STUDY. (12th June 2019) Authors: Witzig, T.; Sokol, L.; Kim, W.; Foss, F.; Jacobsen, E.; de la Cruz Vincente, F.; Caballero, D.; Advani, R.; Roncero Vidal, J.M.; Marin‐Niebla, A.; Rodriguez Izquierdo, A.; de Ona Navarrete, R.; Terol, M.J.; Domingo‐Domenech, E.; Rodriguez, M.; Piris, M.A.; Bolognese, J.; Janes, M.R.; Burrows, F.;... Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗